Refresh

Ankur Drugs & Pharma Ltd. - Research Center

531683 ANKURDRUGS Group (T) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Dec' 12 Sep' 12 Jun' 12 Mar' 12 Dec' 11

Sales

36.12 35.51 33.27 37.94 38.50

Operating profit

-1.52 -0.82 -2.89 -11.45 -7.42

Interest

14.12 6.16 43.81 36.86 14.09

Gross profit

-15.63 -6.97 -46.68 -48.30 -21.51

EPS (Rs)

-21.12 -12.13 -32.83 -61.81 -18.94
Quarterly  results in details
Dec' 12 Sep' 12 Jun' 12 Mar' 12 Dec' 11

Other income

0.01 0.01 0.02 0.01 0.01

Stock adjustment

-1.10 -1.89 1.35 1.37 4.02

Raw material

26.60 26.29 21.62 30.37 24.97

Power and fuel

- - - - -

Employee expenses

5.02 5.12 5.78 6.54 7.14

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

7.12 6.82 7.41 11.10 9.78

Provisions made

- - - - -

Depreciation

16.50 16.50 16.81 16.61 15.12

Taxation

- - - 31.27 -

Net profit / loss

-40.84 -23.47 -63.49 -119.55 -36.62

Extra ordinary item

-8.71 - - -23.37 -

Prior year adjustments

- - - - -

Equity capital

19.34 19.34 19.34 19.34 19.34

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

182.01 170.40 170.40 161.21 159.35

Agg.of non promotoholding (%)

94.10 88.10 88.10 83.35 82.38

OPM (%)

-4.21 -2.32 -8.69 -30.19 -19.28

GPM (%)

-43.27 -19.63 -140.25 -127.28 -55.85

NPM (%)

-113.04 -66.06 -190.74 -315.02 -95.11
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com